|Written by Rob Goldman|
It is a new year and that means new ideas. In this week’s issue of The Goldman Guide we identify new themes that will drive stocks in the near term and stocks to play that leverage these themes such as this week’s CES show. Plus, for those investors seeking modest returns, we outline the most efficient and best way to engage in the Dogs of the Dow investment strategy which entails investing in the highest yielding stocks in the Dow Jones. (Hint: There is a low-priced ETF/ETN.)
…last year, our small cap pick of the year, Orbotech (NASDAQ – ORBK), rose 39% for the year. For 2016, we not only identify our new small cap pick of the year but also a bottom fishing candidate trading under $2 that could jump 60% in 2016. The chart looks terrible and it dropped by 56% last year but oftentimes this year’s biggest winners are the worst performers of the year before. This stock seems primed to fit that bill.
BEST STOCKS AND THEMES FOR 2016
Welcome to 2016! You will no doubt continue to be bombarded with theories and ideas about the market, sectors, and stocks in the coming days. Some of the ideas are short term while other themes may take a while to play out. Since we recognize that we all have to get back into the work swing of things, we are going to highlight these items in a concise and direct manner. Enjoy!
5 Near Term Themes:
#1: The beginning of the year usually brings more buyers than sellers to the forefront, driving stocks early on. However, the market will likely remain driven by oil prices to some degree—where oil goes, so goes stocks. The latest Saudi Arabia/Iran conflict could be a short-term double edge sword (prices higher for oil but prices lower for other stocks due to geopolitical concerns) so I would not play oil purely on this theme.
#2: Talk about stricter gun control laws via Obama Executive Order is just another point for our Smith & Wesson (NASDAQ—SWHC—$21.98—NR) pick. It may up big in the past year or so but these types of themes could existing prolong upward trends.
#3: Slowdown in key Asian manufacturing segments (in China and Korea) could weigh on stocks in conjunction with oil price declines on demand reductions.
#4: The start of the CES show Wednesday means that virtual reality, wearables and OTT (Over The Top Television) segments will be in focus.
Two stocks that will benefit from CES and these themes beyond include FitBit (NYSE—FIT—$29.59—NR) and Immersion (NASDAQ—IMMR—$11.66—NR). While you are no doubt familiar with FIT, IMMR is likely an unknown name, unless you are a 30-30 subscriber.
With 2000 patents to its name, Immersion is the leading innovator of a touch technology known as haptics. The company provides touch feedback solutions to create realistic experiences that enable and enhance digital interactions. Immersion's technology has been adopted via license in more than 3 billion digital devices that include mobile, automotive, gaming, medical, and consumer electronics developed by world-class companies. One of the fastest growing applications is the use of the technology in devices used in virtual reality gaming such as wearables, gaming controllers, and even smart phones and tablets. With adoption of the technology accelerating, a 25-30% rise in the stock in the coming months is in the cards.
Separately, MobileEye (NASDAQ—MBLY—$42.28-NR) is the global leader in the development of vision and data analysis for Advanced Driver Assistance Systems and autonomous driving. The technology reduces the risks of traffic accidents, saves lives and has the potential to revolutionize the driving experience by enabling autonomous driving. It too could see some play. (Note: Stock is down about 18% since we profiled it a few months ago but we like it now more than ever.)
#5: Last year the Dogs of the Dow strategy performed better than most investment strategies and at least on the big cap side, we expect it history to repeat itself. The Dogs of the Dow approach, which traces its roots to 1991, purports that the best performing Dow Jones Industrial Average stocks for a given year tend to be the 10 highest dividend yielding stocks as of the last trading day of the year prior.
There are trading vehicles like closed end funds and a Dogs of the Dow ETF ELEMENTS Dogs of the Dow DJ HY Sel 10 TR ETN (NYSE—DOD—$15.51—NR), for those interested in playing this strategy. The top dividend-paying stocks this year include Verizon (NYSE—VZ—$46.22—NR), Chevron (NYSE—CVX—$89.96—NR), and Caterpillar (NYSE—CAT—$67.96 - NR), which all yield 4.53% annual dividends or higher. (Caution: CVX was a poor performer in 2015 due to low oil prices).
Industry and Small Cap Picks of the Year
In 2015, our small cap picks, by and large had a great year. For example, our pick of the year, Orbotech (NASDAQ—ORBK—$22.13—NR) ended the year up 39.4%. Others, such as Skechers (NYSE—SKX—NR) rose by over 125%. We had our share of stinkers, to be sure, such as JG Wentworth (NYSE—JGW—NR), that we did not pull of the recommended list fast enough.
Speaking of timing, in a year that should see modestly positive returns, we believe that oil-related stocks will bottom in the spring and could be the biggest winner (as an industry) for the entire year. Still, it is too early to dip your toes in the space at this time.
Upon further review, we have selected last week’s featured stock, Rovi Corp (NASDAQ—ROVI—$16.66—NR) as our small cap pick of the year. As we noted last week, with over 5,000 patents issued or pending worldwide, Rovi licenses its technology to providers that enable consumers to navigate content across multiple devices and screens via guides, metadata and recommendations. Wall Street forecasts a 40% increase in EPS next year from $1.43 to $2.01 for this software leader, on a 12% rise in revenue from $509 million to $570 million. Despite the huge expected increase in EPS next year, the stock trades at a ridiculous 8x earnings! Our target price is $28, which is just above Rovi’s 52-week high and reflects a 14x multiple on projected 2016 EPS.
Bonus Bottom-Fishing Microcap Pick:
We have mentioned that big losers in 2015 could be big winners in 2016. Down 56% for the year, Hovnanian Enterprises (NYSE—HOV—$1.81—NR) charts looks terrible which is one reason to consider it!
Nonetheless, current EPS expectations call for EPS to grow from $0.22 for fiscal 2016 ended in October 2015 to $0.46 next year. At recent prices, even if forecasts are cut by a third, the stock is still attractive, as the well-known $2.8 billion in annual sales national homebuilder trades at a P/E valuation that is much lower than the 10x afforded its peers. Our target is $2.75, which reflects a 6x P/E multiple. If the EPS ends up at $0.30, or 1/3 lower than current estimates, our target of $2.75 is still a discount to the industry average.
The Stock Market Today
AAII Sentiment Survey (figures rounded)
Ok, let me get this straight. Half of the respondents are Neutral and the other half are evenly divided between Bullish and Bearish? Talk about the epitome of uncertain. I guess the downticks last week spooked investors. Regardless stocks have room to move higher. This is especially the case given low oil prices, lack of sellers early in the year, and the expectation of decent earnings this year. As illustrated below, small stocks offer the best upside relative to their year highs and closed the year at a level lower than in both 2014 and 2013, so we are due for an uptick. Moreover, with the 12-month forward P/E multiple on the Russell 2000 and S&P 500 indices almost identical, small stocks also offer greater value.
Great info, insights, and hard-hitting stories make up this week’s Say What? feature...
Investor’s Business Daily
A quick preview of the CES in Las Vegas this week.
The Wall Street Journal
A very different Trump expose.
The New York Times
Numbers that matter this week.
How could we be left off the list!?!
Alarmist, but noteworthy.
1498 Reisterstown Road, Suite 286 Baltimore Maryland 21208 Phone: 410.609.7100
Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, unless noted, With some exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ. Goldman Small Cap Research members and contributors’ bios, certifications, and experience can be found on our website: www.goldmanresearch.com
This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces non-sponsored and sponsored (paid) investment research. Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
The Firm’s non-sponsored research publications category, Select Research, reflects the Firm’s internally generated stock ideas, along with economic, industry and market outlooks. In virtually all cases, stocks mentioned in Select Research offerings are listed on the NYSE or the NASDAQ. Publications in this category include the weekly newsletter The Goldman Guide, Market Monitor blogs, Special Reports, and premium products such as The 30-30 Report. Goldman Small Cap Research analysts are neither long nor short stocks mentioned in this newsletter.
Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored microcap research ideas that typically carry greater risks than those stocks covered in Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in company-specific Opportunity Research reports, updates and articles.
Goldman Small Cap Research has not been compensated for any content in this issue.
All information contained in this newsletter and in our reports were provided by the companies mentioned via news releases, filings, and their websites or generated from our own due diligence. Economic, market data and charts are provided by a variety of sources and are cited upon publication. Stock performance data and information are derived from Yahoo! Finance and other websites or sources, as noted. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, other firms, or other financial news outlets. Goldman Small Cap Research relied solely upon information provided by companies through filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, blog, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This newsletter does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
Separate from the factual content of our articles about the company featured in this newsletter, we may from time to time include our own opinions about the companies profiled herein, their businesses, markets and opportunities. Any opinions we may offer about the companies are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com.